Previous FIP Digital Events

Catch up with all FIP previous webinars and digital events.

Leveraging pharmacists to minimise the impact of air pollution on health: Policy barriers and drivers

7 September 2021

There is an evolving role for community pharmacists, not only in reactive respiratory illness, but also in supporting proactive individual and community respiratory wellness. However, what needs to change in terms of policy and regulation for these roles to become part of mainstream pharmacy practice? This symposium will mark the United Nations' International Day of Clean Air for Blue Skies, by addressing the drivers and barriers for the full deployment of these services, and discuss the key points of the FIP call to action on this global health priority.

learning objectives:
- Identify prevailing barriers limiting the deployment of services to reduce the impact of air pollution by community pharmacists.
- Describe facilitators and enablers that can influence air pollution service delivery by community pharmacists.
- Understand the policy and regulatory landscape that needs to be established to promote air pollution mitigation services by community pharmacists.

- Lars-Åke Söderlund, President, Community Pharmacy Section FIP, Sweden

-Ema Paulino, Professional Secretary FIP, Portugal 
-Paul Sinclair, Chair of the Board of Pharmaceutical Practice FIP, Australia
-Deana Lykins, Policy & Government Affairs Consultant The Clean Breathing Institute, USA
-Anna Murphy, Consultant Respiratory Pharmacist
University Hospitals of Leicester NHS Trust, United Kingdom
-Job F.M. van Boven, Chair of the Dutch Respiratory Pharmacists Group, Royal Dutch Pharmacist Association (KNMP), The Netherlands